Skip to content

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03806712
Acronym
R-PLQ
Enrollment
45
Registered
2019-01-16
Start date
2019-04-01
Completion date
2019-07-22
Last updated
2019-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological Malignancy, Palliative Care, Platelet Transfusion

Keywords

social representation

Brief summary

Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Interventions

OTHERmulti method questionary (developped by De Rosa, in 1995 and 2014)

questions from an association network according to the subject and the grounded theorise (Glasser and Strauss)

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* major patient * patient with advanced hematological malignancies * patient transfused in platelet regularly (3 time at least in last month) * medical practioner, hematologist, prescribing platelet transfusion at least one per week. * nurse working in hematology, practicing platelet transfusion at lest one peer week.

Exclusion criteria

* minor patient * non communicant patient * non transfused platelet patient * non voluntary patient or hematologist or nurses * non graduated hematologist

Design outcomes

Primary

MeasureTime frameDescription
measure the impact of social representation on platelet transfusion practice3 monthsinner core and peripheral items of platelet transfusion of each participant will be collected until reaching saturation, it's to say that the repetition of some terms will be measured between each interview thank's to a questionnaire of at least two principals opened questions.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026